Literature DB >> 3501439

Calcium-induced serum bone Gla protein variations in preterm newborns.

C E Fiore1, G Di Stefano, M Romeo, L S Malatino, D R Grimaldi, R Foti.   

Abstract

The effect of calcium infusion on osteocalcin(Bone Gla Protein, BGP) serum levels were studied in a group of preterm newborns with bw appropriate for gestational age. Results showed that basal BGP serum levels in preterm newborns are higher than those reported at birth in normal infants. Moreover, calcium infusion induced a significant decrease in BGP values, inversely correlated with serum calcium. Since calcium loading increases both Ca availability for bone formation and BGP affinity for mineral surfaces, reduction of osteocalcin serum levels might reflect a shift of the protein from bloodstream to bone, suggesting an intervention in regulating an effective calcium uptake.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3501439     DOI: 10.1007/BF03348167

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  17 in total

1.  Long-term effects of histamine H2-receptor antagonists on serum parathyroid hormone in chronic renal failure.

Authors:  C E Fiore; M Lunetta; J A Kanis
Journal:  Clin Endocrinol (Oxf)       Date:  1985-09       Impact factor: 3.478

2.  Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone.

Authors:  P A Price; M K Williamson; J W Lothringer
Journal:  J Biol Chem       Date:  1981-12-25       Impact factor: 5.157

3.  Clinical evaluation of bone turnover by serum osteocalcin measurements in a hospital setting.

Authors:  D M Slovik; C M Gundberg; R M Neer; J B Lian
Journal:  J Clin Endocrinol Metab       Date:  1984-08       Impact factor: 5.958

4.  Measurements of gamma-carboxyglutamate and circulating osteocalcin in normal children and adults.

Authors:  C M Gundberg; J B Lian; P M Gallop
Journal:  Clin Chim Acta       Date:  1983-02-28       Impact factor: 3.786

5.  Presence of osteocalcin and related higher molecular weight 4-carboxyglutamic acid-containing proteins in developing bone.

Authors:  P V Hauschka; J Frenkel; R DeMuth; C M Gundberg
Journal:  J Biol Chem       Date:  1983-01-10       Impact factor: 5.157

6.  Serum osteocalcin in the treatment of inherited rickets with 1,25-dihydroxyvitamin D3.

Authors:  C M Gundberg; D E Cole; J B Lian; T M Reade; P M Gallop
Journal:  J Clin Endocrinol Metab       Date:  1983-05       Impact factor: 5.958

7.  Physiologic response to calcium infusion in newborn and adult dogs.

Authors:  A Noguchi; L I Kleinman; R C Tsang
Journal:  Miner Electrolyte Metab       Date:  1983 Mar-Apr

8.  1,25-Dihydroxyvitamin D3 increases synthesis of the vitamin K-dependent bone protein by osteosarcoma cells.

Authors:  P A Price; S A Baukol
Journal:  J Biol Chem       Date:  1980-12-25       Impact factor: 5.157

9.  Turnover rate of skeletal alkaline phosphatase in humans.

Authors:  S Posen; H S Grunstein
Journal:  Clin Chem       Date:  1982-01       Impact factor: 8.327

10.  Changes in plasma bone GLA protein during treatment of bone disease.

Authors:  L J Deftos; J G Parthemore; P A Price
Journal:  Calcif Tissue Int       Date:  1982-03       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.